Men get HPV primarily through sexual contact, including vaginal, anal, and oral sex. The virus also spreads through close skin-to-skin touching during sex, which means penetration isn’t strictly necessary for transmission. HPV is extremely common: roughly one in three men worldwide carry a genital HPV infection at any given time, and the majority never develop symptoms.
How HPV Spreads to Men
HPV passes from person to person through direct contact with infected skin or mucous membranes. Vaginal and anal sex are the most common routes, but oral sex can transmit the virus to the throat, and skin-to-skin genital contact during any sexual activity can be enough. You don’t need to have intercourse to pick it up.
Because HPV infections are overwhelmingly asymptomatic, the person passing it along typically has no idea they’re carrying the virus. There’s no reliable way to tell whether a partner is infected just by looking. This silent spread is the main reason HPV is so widespread.
Why Most Men Never Know They Have It
Most HPV infections in men produce no warts, no pain, and no noticeable changes at all. The immune system quietly handles the virus on its own. In a cohort study of 290 men in the U.S., the median time to clear an HPV infection was about 5.9 months. Around 75% of men tested negative within 12 months of first detection, and by 18 months, clearance rates climbed even higher.
Some infections do cause visible genital warts, which are typically caused by low-risk HPV strains. These warts are treatable but can recur. The more serious concern is the small fraction of infections caused by high-risk strains that persist rather than clear, because persistent infection is what can eventually lead to cancer.
No Approved HPV Test Exists for Men
Unlike cervical screening for women, there is no FDA-approved HPV test for men. No test has been approved for detecting the virus in any area other than the cervix. The CDC does not recommend routine HPV screening in men, partly because infection is so common, partly because most infections resolve on their own, and partly because there’s no adequate treatment for an established infection that hasn’t caused a health problem yet.
In practice, this means most men only learn they’ve had HPV if they develop genital warts or, far less commonly, an HPV-related cancer. This lack of a screening tool makes prevention all the more important.
Oral HPV and Throat Cancer Risk
About 10% of men carry an oral HPV infection, compared to 3.6% of women. Oral HPV is more common with older age. Most oral infections clear without causing harm, but a persistent infection with a high-risk strain can, over years or decades, lead to oropharyngeal cancer (cancer of the back of the throat, base of the tongue, or tonsils).
This is actually the largest category of HPV-related cancer in men by a wide margin. Each year in the U.S., roughly 18,800 oropharyngeal cancers are diagnosed in men in sites where HPV is commonly found, and an estimated 13,600 of those are probably caused by the virus. By comparison, about 2,600 anal cancers and 1,400 penile cancers are diagnosed annually in men, with roughly 2,300 and 900 of those attributable to HPV, respectively. Using tobacco and alcohol together further raises oropharyngeal cancer risk.
How Much Condoms Actually Help
Condoms reduce HPV transmission, but they don’t eliminate it because the virus lives on skin that a condom doesn’t cover. Still, consistent use makes a meaningful difference. Men who always used condoms had about 50% lower odds of testing positive for HPV compared to those who used them less often. For cancer-causing strains specifically, consistent condom users had a 60% to 77% lower risk of infection.
Among men with more than one sexual partner, always using condoms was associated with an even stronger protective effect, cutting the odds of HPV detection by roughly 78%. The key word is “always.” Occasional use offered far less protection than consistent use. In studies, HPV prevalence ranged from about 38% among men who always used condoms to 54% among those who never did.
HPV Vaccination for Men
The HPV vaccine is the most effective tool for preventing infection. It’s recommended for boys and young men starting as early as age 9 and through age 26 for anyone not vaccinated earlier. Some adults between 27 and 45 may also benefit from vaccination if they weren’t adequately vaccinated when younger, though the benefit diminishes with age because most people have already been exposed by then.
The vaccine works by preventing new infections, not by treating existing ones, which is why it’s most effective when given before any sexual activity begins. More than 15 years of follow-up data show that the vaccine provides safe, effective, and long-lasting protection against the HPV types responsible for the vast majority of HPV-related cancers. The current vaccine was studied in more than 15,000 males and females during clinical trials before approval.
If you’re past the recommended age range and weren’t vaccinated, condom use and limiting the number of sexual partners remain the most practical ways to reduce your risk. For anal cancer specifically, men who have sex with men face higher rates and may benefit from discussing screening options with a healthcare provider.